Company Analysis

Rocket One Inc. (RKTO)

Nasdaq: RKTO · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2017
Grade5.0
◀ Past 3.0● Present 5.0▶ Future 6.1
6 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

1 patent granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Rocket One Inc.’s names, not what it holds today.

Patents granted
1
1 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against 1 in 2024 and none in 2023
Applications published
4
1 of them in 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Hoth Therapeutics, Inc. a former name
named as the applicant on its applications, in US
0 granted
4 published
Hoth Therapeutics, Inc. a former name
US, as the owner printed on each patent
1 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 19, 202412,144,815Use of aprepitant for treating Alzheimer's diseasePharmaceuticalsHoth Therapeutics, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Jan 30, 20252025/0032503USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASEPharmaceuticalsHoth Therapeutics, Inc.
Nov 2, 20232023/0346792COMPOSITIONS AND METHODS FOR TREATING LUNG INFLAMMATIONPharmaceuticalsHoth Therapeutics, Inc.
Aug 25, 20222022/0265672USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASEPharmaceuticalsHoth Therapeutics, Inc. · patent 12,144,815 granted from it
Mar 10, 20222022/0074857NANOHOLE ARRAY BASED SENSORS WITH VARIOUS COATINGS AND TEMPERATURE CONTROL FOR COVID-19MeasurementHoth Therapeutics, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton RKTO · research, not advice